{"nctId":"NCT00474058","briefTitle":"Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine","startDateStruct":{"date":"2007-05"},"conditions":["Parkinson's Disease"],"count":287,"armGroups":[{"label":"Rotigotine","type":"EXPERIMENTAL","interventionNames":["Drug: Rotigotine"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"Rotigotine","otherNames":["Neupro"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Early and advanced Idiopathic Parkinson Disease with early morning motor impairment\n\nExclusion Criteria:\n\n* Atypical Parkinsonian syndromes","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Early Morning UPDRS Part III Score","description":"The Unified Parkinson´s Disease Rating Scale Part III score is an accepted and validated sumscore of 14 items for the assessment of motor function in Parkinson´s disease. Each of the 14 items in the UPDRS part III is measured on a scale of 0 to 4, where 0 is normal and 4 represents severe abnormalities.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.0","spread":"7.6"},{"groupId":"OG001","value":"-3.9","spread":"7.3"}]}]}]},{"type":"PRIMARY","title":"Change in Parkinson's Disease Sleep Scale (PDSS)","description":"The Parkinson´s Disease Sleep Scale (PDSS) is a questionnaire with 15 questions to assess sleep and nocturnal disability in Parkinson´s disease. The item- scores can range between 0= never and 4= very often. The PDSS score is a sumscore of all 15 questions.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.9","spread":"7.6"},{"groupId":"OG001","value":"-1.9","spread":"8.2"}]}]}]},{"type":"SECONDARY","title":"Change in Nocturnal Akinesia, Dystonia, and Cramps Score (NADCS)","description":"Subjects were asked to assess nocturnal akinesia, dystonia and cramps, using an ordinal severity scale. While a score of 0= normal and 4= maximal severity, subjects could also rate their symptoms with values of 0.5, 1.5, 2.5, 3.5. The nocturnal akinesia score was used to evaluate motor performance while the dystonia and cramps scores were used to evaluate sleep.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.3","spread":"1.8"},{"groupId":"OG001","value":"-0.9","spread":"2.1"}]}]}]},{"type":"SECONDARY","title":"Change in Number of Nocturias","description":"Nocturia is the need to get up during the night and interrupt sleep in order to urinate. It is a typical nocturnal symptom of Parkinson´s disease. The change from baseline in number of nocturias was used to evaluate improvements in sleep disorders.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.3","spread":"1.3"},{"groupId":"OG001","value":"-0.2","spread":"1.1"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":10,"n":191},"commonTop":["Nausea","Dizziness","Dyskinesia","Headache"]}}}